Alliance for Clinical Trials in Oncology: Rectal Neoplasms trials

The registry lists 10 Rectal Neoplasms studies with Alliance for Clinical Trials in Oncology as lead sponsor. 3 are open to participants now and 5 have results posted.

Phase 2 5Phase 3 4No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment DelaysRecruitingNCT07283939Not applicable
• Family Communications After Genetic TestingRecruitingNCT07143487Not applicable
• Distance-Based Exercise to Preserve Function and Prevent DisabilityRecruitingNCT07059884Not applicable
• PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing SurgeryActive, not recruitingNCT01515787Phase 2/3Results posted
• Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal CancerCompletedNCT00826540Phase 2Results posted
• Laparoscopic-Assisted Resection or Open Resection in Treating Patients With Rectal CancerCompletedNCT00726622Phase 3Results posted
• Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal CancerCompletedNCT00265850Phase 3Results posted
• Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal CancerCompletedNCT00114231Phase 2Results posted
• Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation and Continuing ResponseActive, not recruitingNCT05610163Phase 2/3
• Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal CancerCompletedNCT00023751Phase 2